The Stem Cell, Mesenchymal Cancer and Development Group has published a new scientific article on infantile acute lymphoblastic leukaemia in cells t (4; 11) / MLL-AF4 + B in the prestigious journal Blood
This particular article, under the direction of Dr. Sanjuan-Pla, focuses on what is known about this form of leukaemia, some of the particular characteristics of studying a disease that appears in such young patients, and goes on to mention what the group hopes will be the result of the application of new technologies in this field of research.
The arrival of the L. Shepherd & Associates Series Mark I model 30 Irradiator steps up research on the Campus Clinic-UB
The new machine purchased jointly with funds from the Josep Carreras Foundation and European FEDER funds has been installed in the Shared Platforms Unit at the Faculty of Medicine at the University of Barcelona.
On 23 September Clara Bueno took part in an official event, organised by the AECC and presided by Queen Letizia at the Burgos Evolution Forum, at which she was awarded €150,000 over three years to fund the project entitled “Genome and Cell Reconstruction of acute lymphoblastic leukaemia (ALL) in breast-feeding babies with reordered MLL4F4".
Research by the ALL group will allow doctors to provide more specific treatments for patients that have certain genetic changes
Jordi Ribera and Dr Josep Maria Ribera have published a paper that will have important consequences for patients in treatment for Acute Lymphoblastic Leukaemia (ALL).
El tercer sábado de cada mes de septiembre, Día Mundial del Donante de Médula Ósea, se inicia una semana internacional dedicada a este tipo de donación
As part of the Unstoppable against Leukaemia campaign, which formed part of 2015 Leukaemia Week (21-28 June), on Sunday 21 June more than 300 patients, who either have or have recovered from leukaemia, lymphoma, multiple myeloma or another malignant blood disease, went out onto the streets to raise people's awareness about these diseases and to ask for their help in order to continue our research into them.
This event was held throughout 16 Autonomous Communities and 43 Spanish provinces. Joining the 300 patients and former patients were the families of 58 children and adolescents with these diseases, leukaemia being the most frequent cancer suffered by children. In Barcelona specifically, the families of 50 such patients and former patients met together in the Born district of the city.
This was the fourth year running that the campaign has been held and with every year that passes the event grows in importance. Last year 300 patients throughout the whole of Spain took part raising more than €50,000 through SMS messages of support. These funds were used to invest in a cell separator for the laboratories at the Josep Carreras Leukaemia Research Institute.
Dr Pablo Menéndez’s team have published an article in the prestigious magazine Leukemia on identifying the role of DLL4 in blood cell production
Dr Pablo Menéndez, scientific director at the Clinic-UB Campus from the Josep Carreras Leukaemia Research institute, has just published an article in the prestigious magazine Leukemia,where he explains how the team has identified the role ofthe DLL4 protein in blood cell production, which is a step forward in finding out what goes wrong in the cases in which pro-B acute lymphoblastic leukaemia MLL-AF4 +, which the team is studying, is developed.
The Josep Carreras Foundation and Hospital Clinic in Barcelona sign a cooperation agreement to boost clinical research
The Josep Carreras Foundation will contribute €1,000,000 to Hospital Clinic to renovate and enlarge the Haemato-oncologic Clinical Trial Unit at Hospital Clinic in Barcelona.
This agreement opens the door to collaborations between scientists at the Josep Carreras Leukaemia Research Institute and the doctors and clinical researchers from Hospital Clinic in Barcelona carrying outclinical, translational and basic research.